Correction to: EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third‑ versus second‑generation estradiol and progesterone immunoassays
1 Department of Reproductive Medicine, Dexeus University Hospital, Gran Via Carles, 11171-75, 08028, Barcelona, Spain. [email protected].
2 Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium. [email protected].
3 Department of Clinical Medicine, Faculty of Health, Aarhus University Incuba/Skejby, Building 2, Palle Juul-Jensens Boulevard 82, Aarhus N, 8200, Aarhus, Denmark. [email protected].
4 Laboratory of Hormonology and Tumour Markers, Universitair Ziekenhuis Brussel, Free University of Brussels, Brussels, Belgium.
5 Centre for Reproductive Medicine, University Hospital (UZB), Laarbeeklaan 101, 1090, Jette, Brussels, Belgium.
6 Medical and Scientific Affairs, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany.
7 Medical and Scientific Affairs, Roche Diagnostics International Ltd, Forrenstrasse 2, 6343, Rotkreuz, Switzerland.
8 Biostatistics and Data Management, Roche Diagnostics Operations Inc., 9115 Hague Road, Building R, Indianapolis, IN, 46256, USA.
9 Human Reproduction Unit, IVI-RMA, Plaza de la Policia Local 3, 46015, Valencia, Spain.
The article "EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third‑ versus second‑generation estradiol and progesterone immunoassays.